NMDAR antagonist 1
NMDAR antagonist 1 is an orally bioavailable small molecule that selectively inhibits the NR2B subunit of the NMDA receptor. This selectivity makes it a valuable research tool for investigating neurological pathways in models of pain, depression, and neurodegenerative diseases, both in vitro and in vivo.
Product Specifications
CAS Number
2220162-06-9
Product Name Alternative
NMDAR antagonist 1, NMDAR antagonist1, NMDAR antagonist-1, inhibit, Ionotropic glutamate receptors, Inhibitor, iGluR
Field of Research
Neuroscience, Neuroscience; Pharmacology & Drug Discovery, Pharmacology & Drug Discovery
Purity
96.19% (May vary between batches)
Solubility
DMSO:1.43 mg/mL (3.45 mM)
Smiles
C (NCCC1=CC=C (O) C=C1) (=O) [C@H]2N3C (=NC=4C (C3) =CC (Br) =CC4) CC2
Molecular Formula
C20H20BrN3O2
Molecular Weight
414.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
135542-APC 100 µL
ZEB2 (Zinc Finger E-box-binding Homeobox 2, HRIHFB2411, KIAA0569, Smad-interacting Protein 1, SMADIP1, SIP1, SIP-1, Zinc Finger Homeobox Protein 1b, ZFHX1B, ZFX1B, HSPC082) (APC)
Sign In for Pricing
View Details 